Literature DB >> 18854346

C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis.

B Galarraga1, F Khan, P Kumar, T Pullar, J J F Belch.   

Abstract

OBJECTIVE: RA is a chronic autoimmune inflammatory condition associated with increased cardiovascular morbidity and mortality. Endothelial dysfunction, a marker of early atherosclerotic disease, occurs in some inflammatory diseases but this relationship has not been previously explored within the microvasculature of patients with RA. We therefore assessed forearm microvascular endothelial function in patients with RA and determined its relationship to RA disease activity and inflammation.
METHODS: A total of 128 RA patients with no previous history of cardiovascular disease were evaluated. Endothelium-dependent and -independent forearm skin microvascular function was measured using laser Doppler imaging after iontophoretic delivery of acetylcholine (ACh) and sodium nitroprusside (SNP), respectively. Parameters of RA disease activity and inflammation were also checked.
RESULTS: There was a significant negative correlation between the level of inflammation measured by log(10)CRP and maximum vasodilatation measured by peak ACh response (r(2) = -0.209, P = 0.018, Pearson correlation test). In a multiple regression model, age (beta = -0.449, P < 0.0001) and log(10)CRP (beta = -0.193, P = 0.026) were independently negatively associated with ACh responses. When RA patients were sub-divided according to their systemic inflammatory status (CRP > 10 mg/l vs CRP </= 10 mg/l), the high CRP group showed lower vasodilator responses to ACh [P = 0.018, analysis of variance (ANOVA)] and SNP (P = 0.05, ANOVA) than the low CRP group.
CONCLUSIONS: In this large cross-sectional study, we found for the first time systemic inflammation (CRP) to be independently associated with microvascular dysfunction in patients with RA. This strong correlation was independent of other conventional vascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854346     DOI: 10.1093/rheumatology/ken386

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  21 in total

1.  A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.

Authors:  László Dávida; Vanda Pongrácz; Emir Awad Mohamed; Szilvia Szamosi; Gabriella Szücs; Andrea Váncsa; Orsolya Tímár; Zoltán Csiki; Edit Végh; Pál Soltész; Zoltán Szekanecz; György Kerekes
Journal:  Rheumatol Int       Date:  2019-12-19       Impact factor: 2.631

Review 2.  The role of endothelial function and its assessment in rheumatoid arthritis.

Authors:  Faisel Khan; Bernat Galarraga; Jill J F Belch
Journal:  Nat Rev Rheumatol       Date:  2010-03-30       Impact factor: 20.543

Review 3.  Validated methods for assessment of subclinical atherosclerosis in rheumatology.

Authors:  György Kerekes; Pál Soltész; Michael T Nurmohamed; Miguel A Gonzalez-Gay; Maurizio Turiel; Edit Végh; Yehuda Shoenfeld; Iain McInnes; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2012-02-21       Impact factor: 20.543

4.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

Review 5.  The "Choosing Wisely" initiative in infectious diseases.

Authors:  Clara Lehmann; Reinhard Berner; Johannes R Bogner; Oliver A Cornely; Katja de With; Susanne Herold; Winfried V Kern; Sebastian Lemmen; Mathias W Pletz; Bernhard Ruf; Bernd Salzberger; Hans Jürgen Stellbrink; Norbert Suttorp; Andrew J Ullmann; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2017-03-13       Impact factor: 3.553

Review 6.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

7.  Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis.

Authors:  Yanmei Cheng; Aimin Dang; Naqiang Lv; Qian Gao; Bingwei Chen; Guozhang Liu
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

8.  Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients.

Authors:  Başak Bıyıkoğlu; Nurcan Buduneli; Kenan Aksu; Ayşe Nalbantsoy; David F Lappin; Evren Evrenosoğlu; Denis F Kinane
Journal:  Rheumatol Int       Date:  2013-06-01       Impact factor: 2.631

9.  Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group.

Authors:  Michael A Grandner; Orfeu M Buxton; Nicholas Jackson; Megan Sands-Lincoln; Abhishek Pandey; Girardin Jean-Louis
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

10.  Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.

Authors:  Jonathan Graf; Rebecca Scherzer; Carl Grunfeld; John Imboden
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.